Gibraltar Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,150
Closed -$809K 46
2019
Q3
$809K Sell
8,150
-2,416
-23% -$230K 0.61% 36
2019
Q2
$977K Sell
10,566
-150
-1% -$14.2K 1.01% 26
2019
Q1
$1.01M Hold
10,716
1.02% 28
2018
Q4
$687K Sell
10,716
-29,638
-73% -$2.19M 0.73% 24
2018
Q3
$3.61M Buy
40,354
+90
+0.2% +$7.95K 2.83% 19
2018
Q2
$3.2M Buy
40,264
+225
+0.6% +$18.7K 2.7% 19
2018
Q1
$3.57M Sell
40,039
-5,990
-13% -$575K 3.03% 18
2017
Q4
$4.8M Buy
46,029
+15,603
+51% +$1.76M 3.82% 14
2017
Q3
$4.44M Buy
30,426
+220
+0.7% +$30K 3.91% 14
2017
Q2
$3.92M Hold
30,206
3.92% 14
2017
Q1
$3.76M Buy
30,206
+271
+0.9% +$32.4K 3.53% 16
2016
Q4
$3.46M Buy
+29,935
New +$3.33M 3.22% 18

Other funds holding CELG

Gibraltar Capital Management's CELG Position: Q4 2019 in Review

Gibraltar Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,150 shares — an estimated $809K sold.

Gibraltar Capital Management first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $4.8M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Gibraltar Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Gibraltar Capital Management sold 8,150 Celgene Corp shares in Q4 2019, an estimated $809K.
  • Gibraltar Capital Management first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Gibraltar Capital Management's Celgene Corp position peaked at $4.8M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Gibraltar Capital Management's 13F filing for Q4 2019, filed 21 Jan 2020.